ACRO Biomedical was founded in June 2014 in Kaohsiung, Taiwan, by Dr. Dar-Jen Hsieh and a group of scientists and physicians. ACRO Biomedical develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat and non-collagenous proteins from animal tissues, while keeping the undiminished collagen scaffold as the biomaterial for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc.
View Top Employees from ACRO Biomedical Co., Ltd.Website | http://www.acrobiomedical.com/ |
Revenue | $5 million |
Employees | 13 (10 on RocketReach) |
Founded | 2014 |
Phone | +886 7 695 5569 |
Technologies |
JavaScript,
PHP,
Google Analytics
+5 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Leisure Facilities, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular ACRO Biomedical Co., Ltd. employee's phone or email?
The ACRO Biomedical Co., Ltd. annual revenue was $5 million in 2024.
10 people are employed at ACRO Biomedical Co., Ltd..
The NAICS codes for ACRO Biomedical Co., Ltd. are [54, 5417, 541713, 541, 54171].
The SIC codes for ACRO Biomedical Co., Ltd. are [87, 873].